tiprankstipranks
Ocuphire Pharma (OCUP)
NASDAQ:OCUP

Ocuphire Pharma (OCUP) Ownership - Who Owns Ocuphire Pharma?

946 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
May 24, 2024
Ashwath Jayagopal
Chief Scientific & Dev. Ofc
Bought$6160
May 21, 2024Bought$8750
Mar 25, 2024Bought$4100
Mar 25, 2024Bought$21000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,510,000Insider25.11%10,285,800
964,762Institution3.72%1,524,324
964,762Institution3.72%1,524,324
505,000Insider1.95%797,900
300,000Insider1.16%474,000
239,151Insider0.92%377,859
213,529Institution0.82%337,376
173,336Institution0.67%273,871
78,851Institution0.30%124,585
55,261Institution0.21%87,312

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
964,762Institution3.72%1,524,324
213,529Institution0.82%337,376
173,336Institution0.67%273,871
78,851Institution0.30%124,585
27,073Institution0.10%42,775
21,645Institution0.08%34,199
15,400Institution0.06%24,332
7,984Institution0.03%12,615
6,134Institution0.02%9,692
5,599Institution0.02%8,846

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
675,815Institution2.61%1,135,369
288,947Institution1.11%485,431
55,261Institution0.21%87,312
39,470Institution0.15%61,179
1,858Institution<0.01%2,936

FAQ

Who Owns Ocuphire Pharma (OCUP)?
Currently, no data Available
What percentage of Ocuphire Pharma (OCUP) stock is held by institutional investors?
Currently, no data Available
What percentage of Ocuphire Pharma (OCUP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Ocuphire Pharma (OCUP)?
Chang Ho Ahn owns the most shares of Ocuphire Pharma (OCUP).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis